Itamar Medical Ltd 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2020 to a ratio of 4.91, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2020. Average receivable collection period, for the Itamar Medical Ltd in Dec 31 2020 quarter, has decreased to 74 days, compared to 90 days, in the 0 quarter.

If we take a look into Healthcare sector 422 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2020 from 1646 to 3170.

What is Receivable Turnover Ratio?
What is Itamar Medical Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ITMR Receivables Turnover Ratio	(Dec 31 2020) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Receivable Change	8.35 %	8.44 %	8.35 %	8.35 %	29.35 %
Y / Y Revenue Change	31.28 %	36.06 %	-	-	29.22 %
Receivable Turnover Ratio (TTM)	4.91	4.06	3.86	3.94	4.02
ITMR's Total Ranking	# 3170	# 1646	# 1645	# 0	# 3159
Accounts Receivable average collection period days	74	90	95	93	91
Seq. Receivable Change	-0.08 %	0.08 %	0 %	8.35 %	0 %
Seq. Revenue Change	273.07 %	-	-	-	286.67 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 127
Healthcare Sector	# 423
Overall Market	# 3170

Receivable Turnover Ratio Statistics
High	Average	Low
3.87	3.42	3.19
(Dec 31 2020)		(Dec 31 2019)

ITMR Company Profile • Back to ITMR Efficiency Comparisons • Compare ITMR Receivables Turnover Ratio to its Competitors

Financial Statements
Itamar Medical Ltd 's Accounts Receivable	$ 11 Millions	Visit ITMR's Balance sheet
Itamar Medical Ltd 's Sales TTM	$ 52 Millions	Visit ITMR's Income Statement
Sources of ITMR's Revenues		Visit ITMR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ITMR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ITMR's Growth Rates	ITMR's Roa	ITMR's Inventory Turnover Ratio	ITMR's Dividend Comparisons
ITMR's Profitability Ratios	ITMR's Roi	ITMR's Asset Turnover Ratio	ITMR's Dividend Growth
ITMR's Valuation Ratios	ITMR's Roe	ITMR's Financial Strength Ratios	ITMR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2020	Receivable at quarter ending Dec 31 2020
Atyr Pharma Inc	13.43	$ 10.455 Millions	$ 0.779 Millions
Protalix Biotherapeutics inc	13.05	$ 62.898 Millions	$ 4.821 Millions
Patterson Companies Inc	12.98	$ 5,636.734 Millions	$ 434.166 Millions
Arrowhead Pharmaceuticals Inc	12.96	$ 79.840 Millions	$ 6.162 Millions
Sunlink Health Systems Inc	12.86	$ 58.721 Millions	$ 4.565 Millions
Prothena Corporation Public Limited Company	12.78	$ 0.853 Millions	$ 0.067 Millions
Xencor Inc	12.77	$ 122.694 Millions	$ 9.609 Millions
Ontrak Inc	12.47	$ 82.837 Millions	$ 6.640 Millions
Kadmon holdings inc	12.29	$ 8.288 Millions	$ 0.675 Millions
Dicerna Pharmaceuticals Inc	12.00	$ 164.307 Millions	$ 13.688 Millions
Fate Therapeutics Inc	12.00	$ 31.434 Millions	$ 2.619 Millions
Bellicum Pharmaceuticals Inc	11.89	$ 0.892 Millions	$ 0.075 Millions
Integrated Biopharma Inc	11.81	$ 56.595 Millions	$ 4.793 Millions
Alpha Pro Tech Ltd	11.77	$ 102.700 Millions	$ 8.725 Millions
Outset Medical Inc	11.44	$ 49.935 Millions	$ 4.366 Millions
Ultragenyx Pharmaceutical Inc	11.40	$ 271.030 Millions	$ 23.769 Millions
Intellia Therapeutics Inc	11.27	$ 57.994 Millions	$ 5.145 Millions
National Healthcare Corp	11.24	$ 1,028.217 Millions	$ 91.473 Millions
Musclepharm Corporation	11.23	$ 64.440 Millions	$ 5.737 Millions
Regeneron Pharmaceuticals Inc	11.17	$ 8,497.100 Millions	$ 760.525 Millions
Morphic Holding inc	11.12	$ 44.945 Millions	$ 4.041 Millions
Insulet Corporation	11.05	$ 904.400 Millions	$ 81.825 Millions
Allied Healthcare Products inc	11.00	$ 37.901 Millions	$ 3.447 Millions
American Bio Medica Corporation	10.93	$ 4.147 Millions	$ 0.379 Millions
Cellectis S a	10.91	$ 73.949 Millions	$ 6.777 Millions
Strongbridge Biopharma plc	10.91	$ 30.731 Millions	$ 2.818 Millions
Pharming Group N v	10.78	$ 207.977 Millions	$ 19.296 Millions
Adamas Pharmaceuticals Inc	10.62	$ 74.461 Millions	$ 7.011 Millions
Scienture Holdings Inc	10.47	$ 17.123 Millions	$ 1.636 Millions
Viemed Healthcare Inc	10.44	$ 131.309 Millions	$ 12.584 Millions

Date modified: 2026-08-29T01:15:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.